BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6098742)

  • 1. [Therapeutic effect of ceftizoxime on severe infectious complications in blood disorders. Tohkai Research Group on Infections in Hematopoietic Disorders].
    Shimizu S; Hirano M; Shirakawa S; Minami N; Ohno R; Murase T; Yamamoto M; Mitomo Y; Yamada K; Shiku H
    Jpn J Antibiot; 1984 Dec; 37(12):2494-505. PubMed ID: 6098742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic effectiveness of ceftizoxime on severe infections associated with hematologic disorders].
    Kanamaru A; Nagai K; Masaoka T; Shibata H; Kitani T; Taniguchi N; Horiuchi A; Hasegawa H; Kawagoe H; Hirata M
    Jpn J Antibiot; 1984 Jan; 37(1):136-44. PubMed ID: 6328059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of ceftizoxime intravenous administration in severe infections associated with hematologic disorders. Niigata Infection Study Group].
    Moriyama Y; Shibata A; Ito M; Iizumi T; Watabe T; Sato M; Kurokawa I; Sugiyama K; Sanada M; Nakamura T
    Jpn J Antibiot; 1986 Mar; 39(3):807-14. PubMed ID: 3461176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic effect of ceftizoxime on infection in patients with lung cancer].
    Hiraki S; Ohnoshi T; Tamura M; Kawahara S; Miyamoto H; Nishii K; Kimura I
    Jpn J Antibiot; 1986 Jan; 39(1):87-93. PubMed ID: 3009911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and pharmacokinetic evaluations of ceftizoxime suppositories in children].
    Meguro H; Mashiko J; Shinozaki T; Fujii R
    Jpn J Antibiot; 1985 Oct; 38(10):2838-48. PubMed ID: 3866079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics and clinical evaluation of ceftizoxime (author's transl)].
    Shimizu S; Nobori T; Kawamura Y; Kamiya H; Sakurai M; Izawa T
    Jpn J Antibiot; 1982 Jan; 35(1):171-83. PubMed ID: 6279908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effect of ceftizoxime on infections in aged patients].
    Horiuchi I; Kawamoto T; Tokumo H; Nomura Y; Kajiyama G; Oobayashi M; Matsui Y; Nakagawa K; Nakamura M; Daitoku K
    Jpn J Antibiot; 1986 Jul; 39(7):1671-80. PubMed ID: 3464771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies of ceftizoxime suppositories in respiratory tract infections and urinary tract infections in children].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Nakamura H; Katayama M
    Jpn J Antibiot; 1985 Oct; 38(10):2903-16. PubMed ID: 3866084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical effect of ceftizoxime suppositories].
    Kuramitsu M; Morioka N; Morita H; Wakiguchi H; Ogura H; Kurashige T; Kitamura I
    Jpn J Antibiot; 1985 Oct; 38(10):2962-9. PubMed ID: 2934562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical studies of ceftizoxime suppositories in the pediatric field].
    Sunakawa K; Hirota A; Saito N; Ishizuka Y
    Jpn J Antibiot; 1985 Oct; 38(10):2889-95. PubMed ID: 3866082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fundamental and clinical studies of ceftizoxime suppositories in the pediatric field].
    Sato Y; Iwata S; Akita H; Murai T; Ihara M; Oikawa T; Osano M
    Jpn J Antibiot; 1985 Oct; 38(10):2877-88. PubMed ID: 3908728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical experience with ceftizoxime suppositories in bacterial infections in children].
    Hosoda T; Masuda M; Ichioka T; Miyao M; Kamada K; Yuasa Y; Uyama Y; Tanaka H
    Jpn J Antibiot; 1985 Oct; 38(10):2952-61. PubMed ID: 3866088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics and clinical effects of ceftizoxime in pediatric field (author's transl)].
    Jpn J Antibiot; 1982 Jan; 35(1):113-36. PubMed ID: 6279904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Basic and clinical studies of ceftizoxime suppositories in the pediatric field].
    Kamiya H; Sono R; Kodama K; Kawasaki Y; Ido M; Sakatoku H; Kawamura Y; Shimizu S; Sakurai M
    Jpn J Antibiot; 1985 Oct; 38(10):2917-24. PubMed ID: 3866085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical use of ceftizoxime suppositories in pediatric infection].
    Kida K; Matsuda H
    Jpn J Antibiot; 1985 Oct; 38(10):2970-6. PubMed ID: 3866089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of ceftizoxime in the treatment of respiratory tract infections].
    Shimokata K; Kawachi H; Yamamoto M; Torii Y; Sakai S; Nomura F; Senda Y; Suzuki T; Yasuda Y; Yoshii S
    Jpn J Antibiot; 1985 Apr; 38(4):1029-36. PubMed ID: 3861881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical investigation of ceftizoxime sodium suppositories in the field of pediatrics].
    Sato T; Ueda K; Kuroiwa T
    Jpn J Antibiot; 1985 Oct; 38(10):3057-64. PubMed ID: 3866092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of ceftizoxime in the treatment of complicated urinary tract infections].
    Takaha M; Ichikawa Y; Sagawa S; Sonoda T; Nakamura T; Kotake T; Miki T; Yano H; Itatani H; Shin T
    Hinyokika Kiyo; 1984 Oct; 30(10):1519-29. PubMed ID: 6098179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of ceftizoxime in the pediatric infections (author's transl)].
    Mashiko J; Meguro H; Ozawa S; Togo T; Nonaka C; Hiraiwa M; Fujii R
    Jpn J Antibiot; 1982 Jan; 35(1):1-8. PubMed ID: 6279902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical effects of cefodizime in severe infections complicated with hematological diseases. Hanshin Infection Study Group].
    Teshima H; Masaoka T; Hiraoka A; Horiuchi A; Hasegawa H; Kitani T; Tagawa S; Yonezawa T; Kanayama Y; Take H
    Jpn J Antibiot; 1992 Oct; 45(10):1295-304. PubMed ID: 1479681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.